These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28186692)

  • 1. Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.
    Cho HM; Kim PH; Chang HK; Shen YM; Bonsra K; Kang BJ; Yum SY; Kim JH; Lee SY; Choi MC; Kim HH; Jang G; Cho JY
    Stem Cells Transl Med; 2017 Mar; 6(3):1040-1051. PubMed ID: 28186692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.
    Lee EJ; Choi EK; Kang SK; Kim GH; Park JY; Kang HJ; Lee SW; Kim KH; Kwon JS; Lee KH; Ahn Y; Lee HJ; Cho HJ; Choi SJ; Oh WI; Park YB; Kim HS
    Mol Ther; 2012 Jan; 20(1):155-67. PubMed ID: 22068423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.
    Shalaby SM; El-Shal AS; Zidan HE; Mazen NF; Abd El-Haleem MR; Abd El Motteleb DM
    IUBMB Life; 2016 May; 68(5):343-54. PubMed ID: 26949188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction.
    Li T; Ma Q; Ning M; Zhao Y; Hou Y
    Mol Cell Biochem; 2014 Feb; 387(1-2):91-100. PubMed ID: 24166198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction.
    Lee EJ; Park SJ; Kang SK; Kim GH; Kang HJ; Lee SW; Jeon HB; Kim HS
    Mol Ther; 2012 Jul; 20(7):1424-33. PubMed ID: 22453767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of hMSCs Genome Edited with LEF1 Improves Cardio-Protective Effects in Myocardial Infarction.
    Cho HM; Lee KH; Shen YM; Shin TJ; Ryu PD; Choi MC; Kang KS; Cho JY
    Mol Ther Nucleic Acids; 2020 Mar; 19():1186-1197. PubMed ID: 32069701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.
    Wen Z; Huang W; Feng Y; Cai W; Wang Y; Wang X; Liang J; Wani M; Chen J; Zhu P; Chen JM; Millard RW; Fan GC; Wang Y
    PLoS One; 2014; 9(9):e104666. PubMed ID: 25251394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
    Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord blood-derived mesenchymal stromal cells and small intestinal submucosa hydrogel composite promotes combined radiation-wound healing of mice.
    Lee C; Shim S; Jang H; Myung H; Lee J; Bae CH; Myung JK; Kim MJ; Lee SB; Jang WS; Lee SJ; Kim HY; Lee SS; Park S
    Cytotherapy; 2017 Sep; 19(9):1048-1059. PubMed ID: 28751152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain.
    Park HW; Moon HE; Kim HS; Paek SL; Kim Y; Chang JW; Yang YS; Kim K; Oh W; Hwang JH; Kim JW; Kim DG; Paek SH
    J Neurosci Res; 2015 Dec; 93(12):1814-25. PubMed ID: 26332684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
    Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF
    Chen H; Tang S; Liao J; Liu M; Lin Y
    J Gene Med; 2021 Oct; 23(10):e3369. PubMed ID: 34057770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.